{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T20:12:25Z","timestamp":1743106345918,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":26,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071612040"},{"type":"electronic","value":"9781071612057"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-1205-7_21","type":"book-chapter","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T12:03:16Z","timestamp":1615464196000},"page":"277-286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Single-Cell Analysis of BRAFV600E and NRASQ61R Mutation Status in Melanoma Cell Lines as Method Generation for Circulating Melanoma Cells"],"prefix":"10.1007","author":[{"given":"Joseph W.","family":"Po","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison W. S.","family":"Luk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bavanthi","family":"Balakrishnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Brungs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Azimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Saricilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Therese M.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"issue":"3","key":"21_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1006658","volume":"15","author":"R Nussinov","year":"2019","unstructured":"Nussinov R, Jang H, Tsai CJ, Cheng F (2019) Review: precision medicine and driver mutations: computational methods, functional assays and conformational principles for interpreting cancer drivers. PLoS Comput Biol 15(3):e1006658. https:\/\/doi.org\/10.1371\/journal.pcbi.1006658","journal-title":"PLoS Comput Biol"},{"issue":"10","key":"21_CR2","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.molmed.2017.08.003","volume":"23","author":"D Senft","year":"2017","unstructured":"Senft D, Leiserson MDM, Ruppin E, Ronai ZA (2017) Precision oncology: the road ahead. Trends Mol Med 23(10):874\u2013898. https:\/\/doi.org\/10.1016\/j.molmed.2017.08.003","journal-title":"Trends Mol Med"},{"issue":"4","key":"21_CR3","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.cell.2016.12.015","volume":"168","author":"DM Hyman","year":"2017","unstructured":"Hyman DM, Taylor BS, Baselga J (2017) Implementing genome-driven oncology. Cell 168(4):584\u2013599. https:\/\/doi.org\/10.1016\/j.cell.2016.12.015","journal-title":"Cell"},{"issue":"12","key":"21_CR4","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1158\/1535-7163.MCT-17-0597","volume":"16","author":"YK Chae","year":"2017","unstructured":"Chae YK, Pan AP, Davis AA, Patel SP, Carneiro BA, Kurzrock R, Giles FJ (2017) Path toward precision oncology: review of targeted therapy studies and tools to aid in defining \u201cactionability\u201d of a molecular lesion and patient management support. Mol Cancer Ther 16(12):2645\u20132655. https:\/\/doi.org\/10.1158\/1535-7163.MCT-17-0597","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"21_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00728-3","volume":"12","author":"F Castro-Giner","year":"2020","unstructured":"Castro-Giner F, Aceto N (2020) Tracking cancer progression: from circulating tumor cells to metastasis. Genome Med 12(1):31. https:\/\/doi.org\/10.1186\/s13073-020-00728-3","journal-title":"Genome Med"},{"issue":"16","key":"21_CR6","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.7150\/thno.34337","volume":"9","author":"M Tellez-Gabriel","year":"2019","unstructured":"Tellez-Gabriel M, Heymann MF, Heymann D (2019) Circulating tumor cells as a tool for assessing tumor heterogeneity. Theranostics 9(16):4580\u20134594. https:\/\/doi.org\/10.7150\/thno.34337","journal-title":"Theranostics"},{"issue":"18","key":"21_CR7","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1101\/gad.305805.117","volume":"31","author":"DS Micalizzi","year":"2017","unstructured":"Micalizzi DS, Maheswaran S, Haber DA (2017) A conduit to metastasis: circulating tumor cell biology. Genes Dev 31(18):1827\u20131840. https:\/\/doi.org\/10.1101\/gad.305805.117","journal-title":"Genes Dev"},{"issue":"2","key":"21_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2478\/raon-2019-0024","volume":"53","author":"T Lozar","year":"2019","unstructured":"Lozar T, Gersak K, Cemazar M, Kuhar CG, Jesenko T (2019) The biology and clinical potential of circulating tumor cells. Radiol Oncol 53(2):131\u2013147. https:\/\/doi.org\/10.2478\/raon-2019-0024","journal-title":"Radiol Oncol"},{"issue":"11","key":"21_CR9","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3390\/cancers11111659","volume":"11","author":"V Martini","year":"2019","unstructured":"Martini V, Timme-Bronsert S, Fichtner-Feigl S, Hoeppner J, Kulemann B (2019) Circulating tumor cells in pancreatic cancer: current perspectives. Cancers (Basel) 11(11):1659. https:\/\/doi.org\/10.3390\/cancers11111659","journal-title":"Cancers (Basel)"},{"key":"21_CR10","doi-asserted-by":"publisher","first-page":"324","DOI":"10.12659\/msm.904770","volume":"24","author":"J Li","year":"2018","unstructured":"Li J, Fu W, Zhang W, Li P (2018) High number of circulating tumor cells predicts poor survival of cutaneous melanoma patients in China. Med Sci Monit 24:324\u2013331. https:\/\/doi.org\/10.12659\/msm.904770","journal-title":"Med Sci Monit"},{"issue":"1","key":"21_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0649-2","volume":"7","author":"M Tamminga","year":"2019","unstructured":"Tamminga M, de Wit S, Hiltermann TJN, Timens W, Schuuring E, Terstappen L, Groen HJM (2019) Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors. J Immunother Cancer 7(1):173. https:\/\/doi.org\/10.1186\/s40425-019-0649-2","journal-title":"J Immunother Cancer"},{"issue":"12","key":"21_CR12","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.2217\/bmm-2016-0192","volume":"10","author":"WL Hwang","year":"2016","unstructured":"Hwang WL, Hwang KL, Miyamoto DT (2016) The promise of circulating tumor cells for precision cancer therapy. Biomark Med 10(12):1269\u20131285. https:\/\/doi.org\/10.2217\/bmm-2016-0192","journal-title":"Biomark Med"},{"issue":"2","key":"21_CR13","first-page":"332","volume":"12","author":"XY Li","year":"2020","unstructured":"Li XY, Dong M, Zang XY, Li MY, Zhou JY, Ma JJ, Wang GY (2020) The emerging role of circulating tumor cells in cancer management. Am J Transl Res 12(2):332\u2013342","journal-title":"Am J Transl Res"},{"issue":"52","key":"21_CR14","doi-asserted-by":"publisher","first-page":"E8379","DOI":"10.1073\/pnas.1608461113","volume":"113","author":"SM Park","year":"2016","unstructured":"Park SM, Wong DJ, Ooi CC, Kurtz DM, Vermesh O, Aalipour A, Suh S, Pian KL, Chabon JJ, Lee SH, Jamali M, Say C, Carter JN, Lee LP, Kuschner WG, Schwartz EJ, Shrager JB, Neal JW, Wakelee HA, Diehn M, Nair VS, Wang SX, Gambhir SS (2016) Molecular profiling of single circulating tumor cells from lung cancer patients. Proc Natl Acad Sci U S A 113(52):E8379\u2013E8386. https:\/\/doi.org\/10.1073\/pnas.1608461113","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"21_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-3035-1","volume":"17","author":"S Hinz","year":"2017","unstructured":"Hinz S, Hendricks A, Wittig A, Schafmayer C, Tepel J, Kalthoff H, Becker T, Roder C (2017) Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study. BMC Cancer 17(1):53. https:\/\/doi.org\/10.1186\/s12885-016-3035-1","journal-title":"BMC Cancer"},{"issue":"1","key":"21_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3349\/ymj.2017.58.1.19","volume":"58","author":"HS Park","year":"2017","unstructured":"Park HS, Han HJ, Lee S, Kim GM, Park S, Choi YA, Lee JD, Kim GM, Sohn J, Kim SI (2017) Detection of circulating tumor cells in breast cancer patients using cytokeratin-19 real-time RT-PCR. Yonsei Med J 58(1):19\u201326. https:\/\/doi.org\/10.3349\/ymj.2017.58.1.19","journal-title":"Yonsei Med J"},{"key":"21_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep03970","volume":"4","author":"C Pfitzner","year":"2014","unstructured":"Pfitzner C, Schroder I, Scheungraber C, Dogan A, Runnebaum IB, Durst M, Hafner N (2014) Digital-direct-RT-PCR: a sensitive and specific method for quantification of CTC in patients with cervical carcinoma. Sci Rep 4:3970. https:\/\/doi.org\/10.1038\/srep03970","journal-title":"Sci Rep"},{"issue":"28","key":"21_CR18","doi-asserted-by":"publisher","first-page":"45544","DOI":"10.18632\/oncotarget.17271","volume":"8","author":"KE Aaltonen","year":"2017","unstructured":"Aaltonen KE, Novosadova V, Bendahl PO, Graffman C, Larsson AM, Ryden L (2017) Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy. Oncotarget 8(28):45544\u201345565. https:\/\/doi.org\/10.18632\/oncotarget.17271","journal-title":"Oncotarget"},{"key":"21_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-666","volume":"10","author":"E Obermayr","year":"2010","unstructured":"Obermayr E, Sanchez-Cabo F, Tea MK, Singer CF, Krainer M, Fischer MB, Sehouli J, Reinthaller A, Horvat R, Heinze G, Tong D, Zeillinger R (2010) Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients. BMC Cancer 10:666. https:\/\/doi.org\/10.1186\/1471-2407-10-666","journal-title":"BMC Cancer"},{"issue":"6","key":"21_CR20","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.3892\/or.2018.6342","volume":"39","author":"R Kou","year":"2018","unstructured":"Kou R, Zhao J, Gogoi P, Carskadon S, Chow W, Hwang C, Palanisamy N, Leung C, Wang Y (2018) Enrichment and mutation detection of circulating tumor cells from blood samples. Oncol Rep 39(6):2537\u20132544. https:\/\/doi.org\/10.3892\/or.2018.6342","journal-title":"Oncol Rep"},{"issue":"10","key":"21_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41568-019-0180-2","volume":"19","author":"L Keller","year":"2019","unstructured":"Keller L, Pantel K (2019) Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells. Nat Rev Cancer 19(10):553\u2013567. https:\/\/doi.org\/10.1038\/s41568-019-0180-2","journal-title":"Nat Rev Cancer"},{"key":"21_CR22","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3389\/fgene.2019.00958","volume":"10","author":"E Rossi","year":"2019","unstructured":"Rossi E, Zamarchi R (2019) Single-cell analysis of circulating tumor cells: how far have we come in the -omics era? Front Genet 10:958. https:\/\/doi.org\/10.3389\/fgene.2019.00958","journal-title":"Front Genet"},{"issue":"10","key":"21_CR23","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.3390\/cancers11101595","volume":"11","author":"SB Lim","year":"2019","unstructured":"Lim SB, Lim CT, Lim WT (2019) Single-cell analysis of circulating tumor cells: why heterogeneity matters. Cancers (Basel) 11(10):1595. https:\/\/doi.org\/10.3390\/cancers11101595","journal-title":"Cancers (Basel)"},{"issue":"6","key":"21_CR24","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jmoldx.2020.02.013","volume":"22","author":"S Lu","year":"2020","unstructured":"Lu S, Chang CJ, Guan Y, Szafer-Glusman E, Punnoose E, Do A, Suttmann B, Gagnon R, Rodriguez A, Landers M, Spoerke J, Lackner MR, Xiao W, Wang Y (2020) Genomic analysis of circulating tumor cells at the single-cell level. J Mol Diagn 22(6):770\u2013781. https:\/\/doi.org\/10.1016\/j.jmoldx.2020.02.013","journal-title":"J Mol Diagn"},{"issue":"11","key":"21_CR25","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.15252\/emmm.201404033","volume":"6","author":"B Polzer","year":"2014","unstructured":"Polzer B, Medoro G, Pasch S, Fontana F, Zorzino L, Pestka A, Andergassen U, Meier-Stiegen F, Czyz ZT, Alberter B, Treitschke S, Schamberger T, Sergio M, Bregola G, Doffini A, Gianni S, Calanca A, Signorini G, Bolognesi C, Hartmann A, Fasching PA, Sandri MT, Rack B, Fehm T, Giorgini G, Manaresi N, Klein CA (2014) Molecular profiling of single circulating tumor cells with diagnostic intention. EMBO Mol Med 6(11):1371\u20131386. https:\/\/doi.org\/10.15252\/emmm.201404033","journal-title":"EMBO Mol Med"},{"issue":"1","key":"21_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/btpr.2294","volume":"33","author":"MH Neumann","year":"2017","unstructured":"Neumann MH, Schneck H, Decker Y, Schomer S, Franken A, Endris V, Pfarr N, Weichert W, Niederacher D, Fehm T, Neubauer H (2017) Isolation and characterization of circulating tumor cells using a novel workflow combining the CellSearch\u00ae system and the CellCelector\u2122. Biotechnol Prog 33(1):125\u2013132. https:\/\/doi.org\/10.1002\/btpr.2294","journal-title":"Biotechnol Prog"}],"container-title":["Methods in Molecular Biology","Melanoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1205-7_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T12:07:57Z","timestamp":1615464477000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-1205-7_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9781071612040","9781071612057"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1205-7_21","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"12 March 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}